Peer Review History: A Multicentric Observational Study on Azilsartan to Assess the Efficacy, Safety and Tolerability in the Management of Hypertension in Indian Population: ZEAL Study

Editor(s):

(1) Prof. Abha Chandra, Dean, Integral Institute of Medical Sciences & Research, Integral University, India.

Reviewers:

(1) Daniel Don Nwibo, University of Central Lancashire, UK.

(2) Ann Sedeeq, University of Kansas Medical Center, USA.

(3) Venkata Suresh Babu Agala, Nimra College of Pharmacy, Jawaharlal Nehru Technological University, India.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer Review Report_1 (Daniel Don Nwibo, UK) | File 1 | NA


Stage 2 | Peer Review Report_2 (Ann Sedeeq, USA) | File 1 | NA


Stage 2 | Peer Review Report_3 (Venkata Suresh Babu Agala, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA